M. Carmen Torralba

Dr. M. Carmen Torralba

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2014 in Crystal Growth & Design
Verified
Journal Article
Closed access
MPMarta Pérez-Torralba
Marta Pérez-Torralba
MGM. Ángeles García
M. Ángeles García
CLConcepción López
Concepción López
MTM. Carmen Torralba
M. Carmen Torralba
MTM. Rosario Torres
M. Rosario Torres
JEJosé Elguero
José Elguero

28 August 2015 in Molecules
Verified
Journal Article
Open access
PDF file
CNCarla Isabel Nieto
Carla Isabel Nieto
MCMaría Pilar Cabildo
María Pilar Cabildo
MCMaría Pilar Cornago
María Pilar Cornago
DSDionisia Sanz
Dionisia Sanz
Rosa M ClaramuntRosa M Claramunt
Rosa M Claramunt
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo
A series of new (E)-3(5)-[β-(aryl)-ethenyl]-5(3)-phenyl-1H-pyrazoles bearing fluorine atoms at different positions of the aryl group have been synthesized starting from the corresponding β-diketones. All compounds have been characterized by elemental analysis, DSC as well as NMR (1H, 13C, 19F and 15N) spectroscopy in solution and in solid state. Three structures have been solved by X-ray diffraction analysis, confirming the tautomeric forms detected by solid state NMR. The in vitro study of their inhibitory potency and selectivity on the activity of nNOS and eNOS (calcium-calmodulin dependent) as well as iNOS (calcium-calmodulin independent) isoenzymes is presented. A qualitative structure–activity analysis allowed the establishment of a correlation between the presence/ absence of different substituents with the inhibition data proving that fluorine groups enhance the biological activity. (E)-3(5)-[β-(3-Fluoro-4-hydroxyphenyl)-ethenyl]-5(3)-phenyl-1H-pyrazole (13), is the best inhibitor of iNOS, being also more selective towards the other two isoforms.

24 July 2018 in Molecules
Verified
Journal Article
Open access
PDF file
CNCarla Isabel Nieto
Carla Isabel Nieto
MCMaría Pilar Cornago
María Pilar Cornago
MCMaría Pilar Cabildo
María Pilar Cabildo
DSDionisia Sanz
Dionisia Sanz
Rosa M ClaramuntRosa M Claramunt
Rosa M Claramunt
Jose-Luis LavanderaJose-Luis Lavandera
Jose-Luis Lavandera
A series of fourteen new asymmetrical 1,3-diketone derivatives have been synthesized and evaluated in the ABTS, FRAP and DPPH assays as a new chemotype with antioxidant and drug-like properties. All the compounds displayed low cytotoxicity in comparison to curcumin against the human neuroblastoma SH-SY5Y cell line. Among them, (3Z,5E)-6-(2,5-difluoro-4-hydroxy-phenyl)-1,1,1-trifluoro-4-hydroxyhexa-3,5-dien-2-one (6b) and (3Z,5E)-6-(2,3-difluoro-4-hydroxy-phenyl)-1,1,1-trifluoro-4-hydroxyhexa-3,5-dien-2-one (7b) with excellent solubility and chemical stability in biorelevant media, have also shown a similar Fe+2 chelation behavior to that of curcumin. Additionally, both derivatives 6b and 7b have afforded good neuroprotection activity against H2O2 induced oxidative stress in the same neuronal cell line, with a significant reduction of intracellular ROS levels, in parallel with a good recovery of the Mitochondrial Membrane Potential (ΔΨm). Compounds 6b and 7b with a promising antioxidant and drug-like profile, with low cytotoxic and good neuroprotectant activity, constitute a new interesting chemical class with high potential as new therapeutic agents against neurodegenerative diseases.

2 May 2017 in ChemistrySelect
Verified
Journal Article
Closed access
PDF file
CNCarla Isabel Nieto
Carla Isabel Nieto
AAAna Andrade
Ana Andrade
DSDionisia Sanz
Dionisia Sanz
RCRosa M. Claramunt
Rosa M. Claramunt
MTM. Carmen Torralba
M. Carmen Torralba
JEJosé Elguero
José Elguero

14 October 2020 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
PDF file
MMMarta Marin-Luna
Marta Marin-Luna
PAPilar Sánchez Andrada
Pilar Sánchez Andrada
Ibon AlkortaIbon Alkorta
Ibon Alkorta
JEJosé Elguero
José Elguero
MTM. Carmen Torralba
M. Carmen Torralba
Rosa M ClaramuntRosa M Claramunt
Rosa M Claramunt

28 March 2018 in Acta Crystallographica Section C Structural Chemistry
Verified
Journal Article
Closed access
PDF file
MFM. Ángeles Farrán
M. Ángeles Farrán
MBM. Ángels Bonet
M. Ángels Bonet
Rosa M ClaramuntRosa M Claramunt
Rosa M Claramunt
MTM. Carmen Torralba
M. Carmen Torralba
Ibon AlkortaIbon Alkorta
Ibon Alkorta
JEJosé Elguero
José Elguero